Hematopoietic SCT for the treatment of multiple sclerosis.
Bone Marrow Transplant. 2010 Aug 9; Hematopoietic SCT for the treatment of multiple sclerosis. Atkins H Abstract Multiple sclerosis (MS) is the leading autoimmune indication for autologous hematopoietic SCT (aHSCT). Patient selection criteria and transplant interventions have been refined through a series of cohort and registry studies. High- and low-intensity chemotherapy-based conditioning regimens have been…